Table 3.
Variable | OR | 95% CI | P‐value |
---|---|---|---|
Treatment vs. placebo | 154 | 75–317 | < 0·001 |
Visit | < 0·001 | ||
Visit (3 vs. 11) | 0·25 | 0·1–0·58 | |
Visit (4 vs. 11) | 0·33 | 0·14–0·75 | |
Visit (6 vs. 11) | 0·87 | 0·42–1·78 | |
Visit (8 vs. 11) | 0·87 | 0·42–1·79 | |
Visit (10 vs. 11) | 1·25 | 0·65–2·42 | |
Age (+ 1 year) | 1·03 | 0·97–1·08 | 0·33 |
Sex: female (ref, male) | 0·56 | 0·26–1·21 | 0·14 |
Scalp site (ref, hand) | 1·68 | 0·78–3·61 | 0·18 |
Thin subtype (ref, thick) | 3·47 | 1·8–6·66 | < 0·001 |
CI, confidence interval